Demographics (4)
- age - Age of participant (phv00225884.v1.p1)
- age - Age of participant (phv00225884.v2.p1)
- gender - Gender of participant (phv00225885.v1.p1)
- gender - Gender of participant (phv00225885.v2.p1)
Disease Events (1)
- AFFECTION_STATUS - Case - control status of the subject (phv00225879.v1.p1)
Race and Ethnicity (2)
- race - Race of participant (phv00225886.v1.p1)
- race - Race of participant (phv00225886.v2.p1)
Other (20)
- ANALYTE_TYPE - Analyte Type (phv00225890.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00225890.v2.p1)
- BODY_SITE - Body site where sample was collected (phv00225889.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00225889.v2.p1)
- CONSENT - Consent group as determined by DAC (phv00225878.v1.p1)
- IS_TUMOR - Represents tumor sample (phv00225891.v1.p1)
- IS_TUMOR - Represents tumor sample (phv00225891.v2.p1)
- LN_PEAK_CR - Quantitative outcome variable (phv00225887.v1.p1)
- LN_PEAK_CR - Quantitative outcome variable (creatinine measurements) (phv00225887.v2.p1)
- SAMPLE_ID - De-identified Sample ID (phv00225888.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00225888.v2.p1)
- SAMPLE_ID - Sample ID (phv00225881.v1.p1)
- SAMPLE_ID - Sample ID (phv00225881.v2.p1)
- SAMPLE_USE - Sample Use (phv00225882.v1.p1)
- SAMPLE_USE - Sample Use (phv00225882.v2.p1)
- SUBJECT_ID - De-identified Subject ID (phv00225883.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00225883.v2.p1)
- SUBJECT_ID - Subject ID (phv00225877.v1.p1)
- SUBJECT_ID - Subject ID (phv00225880.v1.p1)
- SUBJECT_ID - Subject ID (phv00225880.v2.p1)